DOXORUBICIN Accord liposomal conc perf 50 mg/25ml
7680689610023
CH-68961
L01DB01
07.16.1.
Reimbursement limitations:
DOXORACLI.01
Traitement du sarcome de Kaposi associé au SIDA chez les patients ayant un taux de …
1 / 3
google
Details
- Product number
- 6896102
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- doxorubicini hydrochloridum 50 mg, phosphatidylcholinum ex soja hydrogenatum, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, cholesterolum, histidinum, saccharum, acidum hydrochloridum concentratum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile, q.s. ad suspensionem pro 25 ml corresp. natrium max. 0.7975 mg.
Articles (1)
Doxorubicin Accord liposomal 50 mg/25 ml, Konzentrat zur Herstellung einer Infusionsdispersion
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 339.90
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2025
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68961
- Drug name
- Doxorubicin Accord liposomal, Konzentrat zur Herstellung einer Infusionsdispersion
- Galenic form
- KOIND
- ATC Code
- L01DB01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 09/01/2025
- Authorization expiration date
- 08/01/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DOXORUBICIN Accord liposomal conc perf 50 mg/25ml
- Description (DE)
- DOXORUBICIN Accord liposomal Inf Konz 50 mg/25ml
- Market launch
- 09/01/2025
- Narcotic (BTM)
- No